Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.2B | 2.3B | 2.2B | 1.9B |
Cost of revenue | 1.4B | 1.5B | 1.5B | 1.3B |
Gross profit | 760M | 812M | 714M | 600M |
Operating expense | ||||
Research & development | 180M | 184M | 181M | 158M |
Selling general and admin | 139M | 139M | 129M | 131M |
Other operating expenses | — | — | — | — |
Operating income | 441M | 489M | 404M | 311M |
Non operating interest income | ||||
Income | 4M | 8M | 7M | 7M |
Expense | 77M | 84M | 85M | 82M |
Other income expense | -13M | -63M | -10M | 302M |
Pretax income | 355M | 350M | 316M | 538M |
Tax provision | 15M | 14M | 11M | 25M |
Net income | 340M | 336M | 305M | 513M |
Basic EPS | 1.6 | 1.6 | 1.5 | 2.4 |
Diluted EPS | 1.6 | 1.6 | 1.4 | 2.4 |
Basic average shares | 237.8M | 237.8M | 236.7M | 235.5M |
Diluted average shares | 242.3M | 243.4M | 242.3M | 241.2M |
EBITDA | 509M | 498M | 466M | 367M |
Net income from continuing op. | 340M | 336M | 305M | 513M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |